Table 2c.
Cumulative incidence of invasive contralateral breast cancer (%)
5 years | 10 years | 15 years | 20 years | |
---|---|---|---|---|
Bp (B-17) | 3.3 | 7.2 | 10.3 | 13.4 |
Bp+RT (B-17) | 3.2 | 7.9 | 10.2 | 11.8 |
Bp+RT+placebo (B-24) | 3.6 | 6.9 | 10.8 | – |
Bp+RT+TAM (B-24) | 2.4 | 4.7 | 7.3 | – |